Biotech Deal: Meta-backed Cellular Intelligence has licensed Novo Nordisk’s Parkinson’s cell therapy program (STEM-PD) and will run the next clinical steps, after Novo shut its cell-therapy unit last year—Novo gets an equity stake in Cellular plus potential milestones and royalties. AI in Health: Cellular says its AI platform will speed development and manufacturing, with the candidate already in early human testing and fast-tracked by the FDA. Public Health Watch: The hantavirus cruise outbreak response is still unfolding: Americans are isolating in Nebraska and Atlanta after evacuations, while officials stress the risk to the public remains very low. Policy & Rights: A new argument is gaining traction that hate-speech and extremism laws can be used to crush dissent—raising alarms about how “democratic” speech rules may be repurposed. Nordic-India Diplomacy: PM Modi’s five-nation tour spotlights energy and trade, with stops including the UAE and a Nordic-India summit in Norway. Denmark Tech Angle: Bavarian Nordic lifted its 2026 outlook after a new U.S. contract option for its smallpox vaccine.